Company intelligence / Profile preview

Beckman Coulter

Brea, California, United Statesbeckmancoulter.com ↗

Ownership: Private
Employees: ~12000
Development stage: Commercial

Overview

Beckman Coulter develops and markets a broad portfolio of automated biomedical testing instruments and reagents used globally in clinical laboratories and life science research. Their systems are widely adopted for blood analysis, flow cytometry, immunoassays, genomics workflows, particle analysis, liquid handling automation and more. The company has a legacy of innovation dating back to the first commercial pH meter in the US. It was acquired by Danaher Corporation in 2011. No current drug development pipeline.

Therapeutic areas: OncologyWomen's HealthHematologyOtherInfectious Diseases
Modalities: DeviceDiagnostic systemReagent kitMonoclonal antibody (limited; historical cancer research and diagnostics)
Industry: Molecular Diagnostics

Partnerships

Chinese government partnership for prenatal screening expansion

Beyond the preview

Go deeper on Beckman Coulter.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beckman Coulter.

Explore the full profile